Free‐Hand Endoscopic Full‐Thickness Resection for Duodenal Subepithelial Lesions
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.16878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Peirong Xu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Duodenal Neoplasms, Endoscopic Mucosal Resection, Duodenoscopy, Duodenum. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Shanghai Municipal Science and Technology, National Key R&D Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background and Aim This work aims to evaluate the efficacy and safety of free‐hand endoscopic full‐thickness resection (EFTR) for duodenal subepithelial lesions (SELs).
Methods
We performed a retrospective review of 105 patients with duodenal SELs who underwent free‐hand EFTR. Free‐hand EFTR means no other devices (over‐the‐scope clip or full‐thickness resection device) are required. The preoperative baseline data, procedure‐related characteristics, and postoperative outcomes were analyzed.
Results
The technical success rate was 99.0%, and the en bloc resection rate was 94.2%. A total of nine (8.7%) patients experienced major postoperative adverse events (AEs). The incidence of major AEs was significantly higher for lesions with a maximum diameter ≥ 2 cm (30.4%) than for lesions with a maximum diameter < 2 cm (2.6%) ( p < 0.001). There were also significant differences in the incidence of major AEs for peri‐ampullary lesions (37.5%), bulb lesions (4.8%), bulb‐descending junction lesions (6.7%), and descending part lesions (12.5%) ( p = 0.032). Multivariable regression analyses revealed that the maximum diameter ≥ 2 cm (OR = 18.108; 95% CI = 1.881–174.281; p = 0.012) and lesions located in peri‐ampullary (OR = 18.950; 95% CI = 1.219–294.648; p = 0.036) were independent risk factors for major AEs. The mean duration of the follow‐up period was 36.6 ± 21.3 months, and only one patient with gastrointestinal stromal tumors recurred.
Conclusions
Free‐hand EFTR is a safe and effective technique for nonampullary duodenal SELs with a maximum diameter of < 2 cm. Given the complexity of the duodenal anatomy, this procedure should be performed by experienced endoscopists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
- Endoscopy Center of Zhongshan Hospital, Shanghai Collaborative Innovation Center of Endoscopy, Shanghai, China.
- School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
ORCID-Profile: Pinghong Zhou, Hao Hu
Förderung
- Shanghai Municipal Science and Technology
- National Key R&D Program
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Xu, P., Liu, Z., Wang, L., Qu, Y., Xu, C., Xiang, A., Su, W., Tan, T., Zhang, J., Yao, L., Xu, M., Zhong, Y., Li, Q., Zhou, P., & Hu, H. (2025). Free‐Hand Endoscopic Full‐Thickness Resection for Duodenal Subepithelial Lesions. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16878
Vancouver
Xu P, Liu Z, Wang L, Qu Y, Xu C, Xiang A, et al. Free‐Hand Endoscopic Full‐Thickness Resection for Duodenal Subepithelial Lesions. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16878
BibTeX
@article{Xu2025,
author = {Xu, Peirong and Liu, Zuqiang and Wang, Li and Qu, Yifan and Xu, Chenchao and Xiang, Anyi and Su, Wei and Tan, Tao and Zhang, Jiyuan and Yao, Lu and Xu, Meidong and Zhong, Yunshi and Li, Quanlin and Zhou, Pinghong and Hu, Hao},
title = {Free‐Hand Endoscopic Full‐Thickness Resection for Duodenal Subepithelial Lesions},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.16878}
}
EUVIMED